A5103213344- Palliative Care and End-of-Life Issues
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Myeloid Leukemia Treatments
- Immunodeficiency and Autoimmune Disorders
- BRCA gene mutations in cancer
- Eosinophilic Disorders and Syndromes
- Economic and Financial Impacts of Cancer
- Iron Metabolism and Disorders
- Blood disorders and treatments
- Diabetic Foot Ulcer Assessment and Management
- Infective Endocarditis Diagnosis and Management
- Bacterial Identification and Susceptibility Testing
- Pain Management and Opioid Use
- Advances in Oncology and Radiotherapy
- Biosensors and Analytical Detection
- Cancer Genomics and Diagnostics
- Radiomics and Machine Learning in Medical Imaging
- Advanced X-ray and CT Imaging
- Botulinum Toxin and Related Neurological Disorders
- Pain Mechanisms and Treatments
- PARP inhibition in cancer therapy
- Chronic Lymphocytic Leukemia Research
- Pharmacological Effects and Toxicity Studies
- Hematological disorders and diagnostics
- DNA Repair Mechanisms
Ministry of Health
2023
Beaumont Hospital, Troy
2016-2019
Michigan Healthcare Professionals
2019
Beaumont Health
2018
Oakland University
2016-2017
Beaumont Hospital, Royal Oak
2016
Mutations in BRCA1 and BRCA2 (BRCA1/2) genes are associated with an increased risk of breast ovarian cancers women. The cancer characteristics men BRCA1/2 mutations less well studied. This study describes the unique male mutation carriers at our institution.We performed a retrospective chart review on patients who were seen between January 2004 December 2014 tested positive for mutation. We evaluated clinical characteristics, pathology findings, treatment selection survival.A total 102...
Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm resulting from the fusion of BCR-ABL genes, forming Philadelphia chromosome. The diagnosis often suspected when there leukocytosis with left shift and basophilia. Confirmation requires demonstration by polymerase chain reaction. Using data William Beaumont laboratory registry, we conducted retrospective review all orders for tests sent to clinical pathology between March 11, 2014 September 12, 2014. We concluded that presence...
Background: Diabetic peripheral neuropathies are a het-erogeneous group of disorders caused by neuronal dysfunction in patients with diabetes. DPNs cause different pathological changes sensory, Motor and Function levels patients. Aim Study: Was to investigate the effect Kinesio tape resistive exercise on dorsiflexors' functional perform-ance diabetic neuropathy compare between them. Subjects Methods: Forty Type II patients-controlled-diagnosed Physician confirmed Labora-tory investigations...
e13007 Background: BRCA mutations are associated with an increased risk of breast and ovarian cancers in women. The cancer characteristics men 1 2 less well studied. We reviewed data on male patients diagnosed or our clinical database described their unique characteristics. Methods: After IRB approval, we performed a retrospective chart review seen at the Nancy James Grosfeld Cancer Genetics Center from January 2004 to December 2014, who tested positive for mutation. Results: A total 103...
Microscopic disease analysis stands as a pivotal technique in the realm of infectious diagnosis. Tracing back to 17th century, advent microscopy introduced an unprecedented method directly observing pathogens, profoundly transforming both our comprehension and diagnostic approach diseases. Principal microscopic techniques have come fore, including: light microscopy, invaluable for identifying parasites such Plasmodium; electron delivering superior magnification resolution suitable...
11585 Background: Oncology Care Model (OCM) is an initiative of the Centers for Medicare and Medicaid Innovation which aims to provide higher quality more coordinated oncology care while lowering cost. Division Michigan Health Professionals (MHP) participates in OCM. Palliative End Life was identified as one improvement areas. A community (PC) program launched October 2017. Methods: The multidisciplinary PC team led by Board certified palliative hospice physicians. Patients appropriate...
69 Background: Michigan Health Professionals (MHP) participates in Oncology Care Model (OCM). A community oncology program for early and timely involvement of palliative care (PC) was launched 2017 to achieve OCM goals high quality, cost-effective, coordinated care. Previously, we showed that enrollment PC increased hospice utilization, decreased hospitalization outpatient facility cost last 30-days death or end episode. improved quality patients. This study aims see the effect by patient...
60 Background: Oncology Division of Michigan Health Professionals participates in Care Model (OCM ). A community oncology program for early and timely involvement palliative care (PC) was launched September 2017 to improve cancer pain management. Under-treatment leads continued patient suffering impaired quality life. Appropriate dosing, rotation frequent assessments are essential better control. This study aims see the effect PC on opioid analgesic utilization. Methods: Retrospective claims...